Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview
- PMID: 39100521
- PMCID: PMC11292619
- DOI: 10.33393/grhta.2024.3108
Place in therapy of dalbavancin to treat Gram-positive infections in antimicrobial resistance era: an overview
Similar articles
-
Review: dalbavancin--a novel lipoglycopeptide antimicrobial for gram positive pathogens.Pak J Pharm Sci. 2008 Jan;21(1):78-87. Pak J Pharm Sci. 2008. PMID: 18166524 Review.
-
Update on activity of dalbavancin and comparators against clinical isolates of Gram-positive pathogens from Europe and Russia (2017-2018), and on clonal distribution of MRSA.Int J Antimicrob Agents. 2022 Feb;59(2):106503. doi: 10.1016/j.ijantimicag.2021.106503. Epub 2021 Dec 18. Int J Antimicrob Agents. 2022. PMID: 34929289
-
The role of dalbavancin for Gram positive infections in the COVID-19 era: state of the art and future perspectives.Expert Rev Anti Infect Ther. 2021 Sep;19(9):1125-1134. doi: 10.1080/14787210.2021.1894130. Epub 2021 Mar 16. Expert Rev Anti Infect Ther. 2021. PMID: 33682593 Review.
-
A comparative review of the lipoglycopeptides: oritavancin, dalbavancin, and telavancin.Pharmacotherapy. 2010 Jan;30(1):80-94. doi: 10.1592/phco.30.1.80. Pharmacotherapy. 2010. PMID: 20030476 Review.
-
Antimicrobial spectrum and potency of dalbavancin tested against clinical isolates from Europe and North America (2003): initial results from an international surveillance protocol.J Chemother. 2005 Dec;17(6):593-600. doi: 10.1179/joc.2005.17.6.593. J Chemother. 2005. PMID: 16433188
References
-
- Magiorakos AP, Srinivasan A, Carey RB et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clin Microbiol Infect. 2012;18(3):268–281. doi: 10.1111/j.1469-0691.2011.03570.x. - DOI - PubMed
-
- Glasner C, Berends MS, Becker K et al. A prospective multicentre screening study on multidrug-resistant organisms in intensive care units in the Dutch-German cross-border region, 2017 to 2018: the importance of healthcare structures. Euro Surveill. 2022;27(5):1. doi: 10.2807/1560-7917.ES.2022.27.5.2001660. - DOI - PMC - PubMed
Publication types
LinkOut - more resources
Full Text Sources